Keyphrases
Methotrexate
94%
Oral mucositis
57%
Acute Lymphoblastic Leukemia
52%
High-dose Methotrexate (HD-MTX)
46%
Leucovorin
41%
Pediatric Acute Lymphoblastic Leukemia
32%
Rescue Therapy
24%
Leucovorin Rescue
22%
Global DNA Methylation
22%
Invasive Fungal Infection
22%
Folate Levels
20%
Meta-analysis
15%
Mucositis
15%
Solid Tumors
14%
Pediatric Cancer Patients
14%
Childhood Acute Lymphoblastic Leukemia
14%
Patient Outcomes
13%
Induced Toxicity
13%
Wilms Tumor
13%
Infections in children
13%
Red Blood Cell Folate
12%
Folate Metabolism
12%
Genetic Variants
12%
Odds Ratio
11%
Single nucleotide Polymorphism
11%
Oral mucosa
11%
In Vitro Model
11%
Patient-derived
11%
Organoids
11%
Thymidylate Synthase Gene
11%
Global DNA Hydroxymethylation
11%
Trimester
11%
Interprofessional Training Ward
11%
Student Learning Outcomes
11%
Clinical Characteristics
11%
25(OH)D3
11%
Hepatopathy
11%
Storage Conditions
11%
Storage Temperature
11%
Vitamin D Status
11%
Hematological Malignancies
11%
Solid Malignancies
11%
Stem Cell Transplantation
11%
Methotrexate Clearance
11%
Systematic Meta-analysis
11%
MicroRNA
11%
Narrative Review
11%
Cancer Treatment
11%
Methotrexate Levels
11%
Pediatric Malignancy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Methotrexate
100%
Acute Lymphoblastic Leukemia
69%
Oral Mucositis
56%
Folinic Acid
29%
Childhood Cancer
22%
Malignant Neoplasm
16%
Mucosa Inflammation
13%
Nephroblastoma
13%
Folic Acid
13%
Prevalence
12%
Systemic Mycosis
11%
Solid Malignant Neoplasm
11%
Thymidylate Synthase
11%
Ethylenediaminetetraacetic Acid
11%
Chemotherapy
11%
Vitamin D
11%
Clinical Feature
11%
Disease
11%
Liver Disease
11%
Mixed Model
11%
Pharmacogenetics
11%
microRNA
11%
Pharmacokinetics
11%
Hypovitaminosis D
7%
Vitamin D Deficiency
7%
